Beta HCG-Titre, in Visit Clinic

Beta hCG titer is the measured concentration of the pregnancy hormone beta–human chorionic gonadotropin in blood or urine. Reported in mIU/mL, it confirms pregnancy, estimates gestational age early, and monitors viability or complications (ectopic, miscarriage, molar pregnancy). Serial titers and expected doubling times help assess normal progression or abnormal outcomes. It's also used to follow treatment of trophoblastic disease and some cancers.

Beta hCG levels vary widely by gestational age. Non-pregnant values are <5 mIU/mL. Typical ranges: about 5–426 mIU/mL at 4 weeks, 1,080–56,500 by 6 weeks, and 25,700–288,000 at 9–12 weeks, then decline. Early pregnancy levels usually rise rapidly, roughly doubling every 48–72 hours; clinicians interpret results using serial measurements and ultrasound.

hCG titre (titer) is the measured concentration of human chorionic gonadotropin in blood, reported in mIU/mL. It confirms pregnancy, estimates early gestational progression, and monitors viability or abnormal pregnancies (ectopic, molar) or treatment response. A level above about 5 mIU/mL is often considered positive; in early normal pregnancy hCG typically rises roughly doubling every 48–72 hours.

To confirm pregnancy, start with a urine pregnancy test (best with first‑morning urine) for a qualitative result. For confirmation, get a serum quantitative beta‑hCG: values above ~5 mIU/mL indicate pregnancy. Repeat quantitative testing after 48 hours; a viable early pregnancy usually shows roughly doubling every 48–72 hours. When serum hCG reaches ~1500–2000 mIU/mL, a transvaginal ultrasound can usually locate an intrauterine gestation—consult your clinician.

No — a single quantitative beta-hCG test does not reliably confirm fetal sex. hCG levels vary widely and any small average differences between male and female pregnancies overlap too much to be diagnostic. Accurate determination comes from fetal anatomy ultrasound (generally ~18–20 weeks), noninvasive prenatal testing using cell‑free fetal DNA (from ~10 weeks), or diagnostic genetic tests (CVS/amniocentesis).

No single β-hCG value diagnoses ectopic pregnancy. The transvaginal ultrasound "discriminatory zone" is about 1,500–2,000 mIU/mL: if levels exceed this and no intrauterine sac is seen, ectopic is likely. Serial quantitative β-hCGs are critical—failure to rise appropriately over 48 hours, plateau, or decline suggests ectopic or nonviable pregnancy. Clinical correlation and imaging are required.